Search Videos and More
Grants Awarded to Expand Clinical Trials Navigation
Researchers receive funding from several prestigious sources to help patients from diverse backgrounds access and navigate clinical trials.Cardio-Oncology Program Recognized as Global Center of Excellence
The program was one of few in the world to be recognized with the highest distinction in 2022 by the International Cardio-Oncology Society.Preventing Lineage Plasticity in Prostate Cancer Cells Resensitizes Them to Therapy
UTSW study suggests combination therapy might help prostate cancer patients overcome resistance to AR-targeted therapy.Clarifying the Mechanics of Brain Metastasis in Breast Cancer
A new study reveals how breast cancer metastasizes in the brain and how metabolic diversity and plasticity dictate its spread.Some cervical cancer patients at higher risk for UTIs after radical hysterectomies
Women with early-stage cervical cancer had significantly higher chances of developing catheter-associated urinary tract infections (CAUTIs) after radical hysterectomies if they were smokers or used a catheter for more than seven days post-surgery, UT Southwestern Medical Center researchers found in a study.Carlos Arteaga, M.D., Named to Susan G. Komen® Research Scholar Group
Director of UTSW’s Simmons Cancer Center is one of nine new Komen Scholars who will help guide the organization’s breast cancer research programs.UT Southwestern: A global leader in robotic pancreas surgery
Traditionally performed through a large incision, at UT Southwestern our pancreatic cancer surgeons have specialized in robotic-assisted Whipple surgery, a more precise approach through smaller incisions that has been proven to benefit patients with faster recovery times, less pain, less use of pain medication, and prompter return to work. It has also been shown to have comparable cancer treatment results with lower rates of complications and transfusions than the open surgery.Response to Hormone Therapy Predicts Radiation Resistance in ER+ Breast Cancer
How estrogen receptor-positive (ER+) breast cancer responds to hormone therapy may hold keys to understanding how it will respond to radiation therapy, and an experimental drug that increases the effectiveness of hormone therapy also overcomes radiation resistance in breast cancer, a study by UT Southwestern Medical Center researchers shows.Robotic Nipple-Sparing Mastectomy at UT Southwestern
When Renee Mallonee found out she was BRCA2 positive and her lifetime risk of breast cancer was high, she took this news very seriously. After 15 years of screenings and tests every 6 months, she turned to UT Southwestern for a prophylactic mastectomy.Liver cancer treatment costly for Medicare patients, UT Southwestern study finds
Hepatocellular carcinoma (HCC), the most common type of liver cancer, can place a significant financial burden on patients, according to an analysis led by a researcher at UT Southwestern Medical Center.Using Artificial Intelligence to Personalize Lung Cancer Treatment
UT Southwestern research combining artificial intelligence with traditional pathology analysis holds potential for quickly creating a personalized attack plan for cancer patients when speed is essential: as non-small cell lung cancers spread. This approach identified lung cancers that are most likely to respond to one common treatment versus those that might benefit from a different approach.New Drug Combination Offers Hope for Improved Treatment of Cervical Cancer
A new combination of drugs slowed the growth of cancer cells by an unexpected mechanism that may one day lead to improved treatment of cervical cancer, a UT Southwestern-led study published in Molecular Cancer Research suggests.